Sale!

RFT1 Gene Glycosylation Disorder Type 1N Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “RFT1 Gene Glycosylation Disorder Type 1N Genetic Test” is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RFT1 gene. These mutations can lead to a type of Congenital Disorder of Glycosylation (CDG), specifically Type 1N, which is a rare genetic condition. CDGs are a group of inherited metabolic disorders that affect the glycosylation process, a critical biochemical pathway responsible for the proper function and structure of most proteins and lipids in the body.

Type 1N CDG, linked to the RFT1 gene, can manifest in various clinical symptoms, including developmental delay, neurological issues, and other systemic complications. Early and accurate diagnosis through genetic testing is crucial for managing the condition, as it can guide treatment options and help in understanding the prognosis.

The test at DNA Labs UAE involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific mutations in the RFT1 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the advanced technology used in detecting these genetic variations. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of their condition, enabling more personalized and effective care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RFT1 Gene Glycosylation Disorder Type 1N Genetic Test

Welcome to DNA Labs UAE, where we offer the RFT1 Gene Glycosylation Disorder Type 1N Genetic Test. This test is designed to diagnose and provide valuable information about Congenital Disorder of Glycosylation Type 1N (CDG1N), a glycosylation disorder associated with the RFT1 gene.

Test Details

The RFT1 gene is responsible for glycosylation, the process of attaching sugar molecules to proteins. When this gene is affected, it can lead to a wide range of symptoms. Our NGS (Next-Generation Sequencing) genetic testing utilizes advanced sequencing technologies to analyze multiple genes simultaneously. For CDG1N, we focus on the RFT1 gene to identify any mutations or variations that may be causing the disorder.

Test Components and Price

The RFT1 Gene Glycosylation Disorder Type 1N Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card for analysis.

Report Delivery

After sample collection, the report will be delivered within 3 to 4 weeks.

Method

We utilize NGS technology for this test, ensuring accurate and efficient analysis of the RFT1 gene.

Test Type

This test falls under the category of Metabolic Disorders, specifically focusing on Congenital Disorder of Glycosylation Type 1N.

Referring Doctor

The RFT1 Gene Glycosylation Disorder Type 1N Genetic Test can be ordered by a General Physician.

Test Department

This test is conducted in our Genetics department.

Pre-Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the RFT1 Gene Glycosylation Disorder Type 1N NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by Glycosylation Disorder Type 1N.

Importance of the Test

By undergoing the RFT1 Gene Glycosylation Disorder Type 1N Genetic Test, individuals can confirm a diagnosis of CDG1N and receive crucial information for genetic counseling, management, and treatment of the disorder. It is essential to note that NGS genetic testing may not be available in all healthcare settings and should be ordered by a genetics specialist. Results should always be interpreted by a qualified healthcare provider who can provide appropriate guidance and support.

Test Name RFT1 Gene Glycosylation disorder type 1N Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RFT1 Gene Glycosylation disorder type 1N NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1N
Test Details

The RFT1 gene is associated with a glycosylation disorder called Congenital Disorder of Glycosylation Type 1N (CDG1N). This genetic disorder affects the body’s ability to properly attach sugar molecules (glycosylation) to proteins, leading to a wide range of symptoms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CDG1N, NGS genetic testing can be used to identify mutations or variations in the RFT1 gene that may be causing the disorder.

NGS genetic testing for CDG1N typically involves obtaining a DNA sample, usually through a blood or saliva sample, and analyzing the RFT1 gene for any mutations or variations. This test can help confirm a diagnosis of CDG1N and provide valuable information for genetic counseling, management, and treatment of the disorder.

It’s important to note that NGS genetic testing may not be available in all healthcare settings, and it is typically ordered by a healthcare professional specializing in genetics. Genetic testing results should always be interpreted by a qualified healthcare provider who can provide appropriate guidance and support.